Bicycle Therapeutics
A Scientist at Bicycle Therapeutics designs and executes translational data packages for clinical oncology assets, contributing to the development of novel drug conjugates and companion diagnostics. The role involves biomarker assay data analysis, cross-functional collaboration, and scientific innovation.
Headquarters
Great Abington, England, United Kingdom
Company Size
201-500 employees
Founded
2009
Bicycle Therapeutics is a clinical-stage biopharmaceutical company that pioneers a proprietary "Bicycle" bicyclic peptide platform to create precision-guided therapeutics. Their modular, constrained peptides are engineered to bind targets with high affinity and can be formatted as multispecific agents or linked to payloads (e.g., cytotoxins or immune modulators) to enable targeted delivery, with a strong focus on oncology and other serious diseases. The company emphasizes rapid tissue penetration, scalable chemistry and strategic collaborations to advance a pipeline of targeted therapies toward clinical development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bicycle Therapeutics.
3% above the average for this role
Executive Director, Companion Diagnostics
MSD
Executive Director, Clinical R&D (Translational Medicine and Companion Diagnostics)
Eikon Therapeutics
Translational Biomarker and CDx Leader
Pierre Fabre Group
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Scientist/Senior Scientist, Companion Diagnostics (CDx) – IHC Development
Systimmune
Oncology Diagnostic Liaison - Seattle / San Francisco / Portland
AbbVie